We compared the cytotoxicity; reactive oxygen species (ROS) and GSH modulations induced by DMF in several human primary tumors, with or without KRAS mutations and confirmed our findings by the genetic modulation of p.G12V KRAS in a Caco-2 colon cancer cell line that is not KRAS mutated. This evidence concerns the gene KRAS and malignant colon neoplasm.